Epidemiological study to describe NSCLC clinical management patterns in Europe. Lung-EPICLIN - EPICLIN

Study identifier:NIS-OEU-DUM-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Epidemiological study to describe Non-small cell lung cancer (NSCLC) clinical management patterns in Europe. Lung

Medical condition

NSCLC

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3513

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jan 2009
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria